Gene therapy of cancer [recurso electrónico] : translational approaches from preclinical studies to clinical implementation / edited by Edmund Lattime, Stanton Gerson.
Tipo de material: TextoEditor: Amsterdam : Academic Press, 2014Edición: Third editionDescripción: 1 online resourceTipo de contenido: text Tipo de medio: computer Tipo de portador: online resourceISBN: 9780123946324; 0123946328Tema(s): Cancer -- Gene therapy -- Laboratory manuals | Cancer -- Immunotherapy | Neoplasms -- genetics | Neoplasms -- therapy | Genetic Therapy -- methods | Immunotherapy -- methods | Protein Biosynthesis | HEALTH & FITNESS -- Diseases -- General | MEDICAL -- Clinical Medicine | MEDICAL -- Diseases | MEDICAL -- Evidence-Based Medicine | MEDICAL -- Internal Medicine | Cancer -- Gene therapy | Cancer -- ImmunotherapyGénero/Forma: Electronic books. | Handbooks, manuals, etc.Formatos físicos adicionales: Print version:: Gene therapy of cancer.Clasificación CDD: 616.994042 Clasificación LoC:RC271.G45 | G485 2014Recursos en línea: Libro electrónico ScienceDirectTipo de ítem | Biblioteca actual | Colección | Signatura | Copia número | Estado | Fecha de vencimiento | Código de barras |
---|---|---|---|---|---|---|---|
Libro Electrónico | Biblioteca Electrónica | Colección de Libros Electrónicos | RC271 .G45 G485 2014 (Browse shelf(Abre debajo)) | 1 | No para préstamo | 380224-2001 |
Includes bibliographical references and index.
Ex Vivo Gene Therapy: Utilization of Genetic Vectors for the Generation of Genetically Modified Cell Products for Therapy -- Targeting Tumor Vasculature Using Adeno-Associated Virus Phage Vectors Coding Tumor Necrosis Factor-a -- Viral Insertion Site Detection and Analysis in Cancer Gene Therapy -- Targeted Systemic Delivery of Therapeutic siRNA -- Bacterial Delivery of RNAi Effectors -- Gene-Directed Enzyme Prodrug Cancer Therapy -- Electroporation Gene Therapy -- Toxin-Based Cancer Gene Therapy: Under the Control of Oncofetal H19 Regulatory Sequences -- Gene Therapy in Radiotherapy of Cancer -- Advances in Oncolytic Virotherapy for Brain Tumors -- Oncolytic Adenoviruses in the Treatment of Cancer in Humans -- Selectively Replicating Oncolytic Adenoviruses Combined with Chemotherapy, Radiotherapy, or Molecular Targeted Therapy for Treatment of Human Cancers -- Reoviral Therapy for Cancer: Strategies for Improving Antitumor Efficacy Using Radio- and Chemotherapy -- Selectively Replicating Herpes Simplex Viral Vectors -- Modified Oncolytic Herpesviruses for Gene Therapy of Cancer -- The Lister Strain of Vaccinia Virus as an Anticancer Therapeutic Agent -- Poxvirus-Based Strategies for Combined Vaccine and Tumor Microenvironment Manipulation -- Genetically Engineered (T Cell Receptor) T Cells for AdoptiveTherapy -- Genetically Modified Dendritic Cell Vaccines for Solid Tumors -- Dendritic Cell Vaccination -- Chemokine Gene-Modified Dendritic Cells for Cancer Therapy -- The Use of T Cell Costimulation to Enhance the Immunogenicity of Tumors -- Clinical Application of Plasmid-Based Cancer Vaccines -- Lentivector Vaccines -- Therapeutic Efficacy and Systemic Antitumor T Cell Immunity Induced by RheoSwitch-Regulated IL-12 Expression after Intratumoral Injection of Adenovirus Vector or Vector-Transduced Dendritic Cells -- Clinical Trials Using LV-P₁₄₀K-MGMT for Gliomas -- RNA Interference Therapeutics for Tumor Therapy: Promising Work in Progress -- MGMT Stem Cell Selection and Protection: Preclinical Large Animal and Clinical Studies -- Cytidine Deaminase in Myeloprotective Gene Therapy -- Genetically Engineered Salmonella typhimurium for Targeted Cancer Therapy -- Imaging of Oncolytic Virus Gene Expression -- Lentiviral-Encoded Sodium Iodide Symporter-Mediated Cancer Gene Therapy -- Bacteriophage: From Bacteria to a Successful Targeted Systemic Gene Delivery for Cancer -- Issues in Moving Gene Therapy Approaches to Early Clinical Trials -- The FDA Review Process for Cancer Gene Therapy -- Ethics in Translational Gene Transfer Research.
Print version record.
19